tiprankstipranks
Satellos Bioscience (MSCLF)
OTHER OTC:MSCLF
Holding MSCLF?
Track your performance easily

Satellos Bioscience (MSCLF) Financial Statements

18 Followers

Satellos Bioscience Financial Overview

Satellos Bioscience's market cap is currently ―. The company's EPS TTM is $-0.185; its P/E ratio is -2.85; Satellos Bioscience is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.04. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -9.05MC$ -6.04MC$ -6.91MC$ -6.53MC$ -3.52M
EBITDAC$ -9.04MC$ -6.03MC$ -6.91MC$ -6.53MC$ -3.52M
Net Income Common StockholdersC$ -9.05MC$ -6.04MC$ -6.91MC$ -6.53MC$ -3.57M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 23.42MC$ 27.70MC$ 33.17MC$ 39.59MC$ 44.26K
Total AssetsC$ 24.21MC$ 33.19MC$ 38.26MC$ 44.30MC$ 48.68K
Total DebtC$ 0.00C$ 0.00C$ 0.00C$ 0.00C$ 0.00
Net DebtC$ -23.42MC$ -27.70MC$ -33.17MC$ -39.59MC$ -44.26K
Total LiabilitiesC$ 3.62MC$ 4.03MC$ 3.75MC$ 3.62MC$ 2.32K
Stockholders EquityC$ 20.59MC$ 29.17MC$ 34.50MC$ 40.67MC$ 46.36K
Cash Flow-
Free Cash FlowC$ -4.38MC$ -5.66MC$ -7.13MC$ -14.51MC$ -3.99M
Operating Cash FlowC$ -4.38MC$ -5.66MC$ -7.13MC$ -14.49MC$ -4.00M
Investing Cash FlowC$ 17.70MC$ 2.35MC$ -2.10MC$ -17.54MC$ -10.13K
Financing Cash FlowC$ 221.00KC$ 16.00K-C$ 50.98MC$ -2.02M
Currency in CAD

Satellos Bioscience Earnings and Revenue History

Satellos Bioscience Debt to Assets

Satellos Bioscience Cash Flow

Satellos Bioscience Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis